Portfolio company
ProVerum Medical
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
The company develops a minimally invasive urethral stent system to treat benign prostatic hyperplasia for urologists and patients.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
ProVerum
This company develops minimally invasive nitinol stents to treat benign prostatic hyperplasia in male patients.
ArgoMed
This company develops water-induced thermotherapy devices for the non-surgical treatment of benign prostatic hyperplasia in male patients.
Alpfa Medical
The company develops pulsed field ablation systems to treat benign prostatic hyperplasia in men.
TRANSURETHRAL IMAGING & THERAPY
This company develops a transurethral ultrasound imaging and high-intensity focused ultrasound therapy system for urologists to treat prostate disease in outpatient procedures.
Trod Medical
The company develops radio frequency ablation devices for treating prostate cancer for use by urological surgeons and healthcare providers.
Promaxo, Inc
The company develops a point-of-care MRI platform for urologists to perform guided prostate biopsies and treatments in clinical settings.
NXThera
This company develops water vapour therapy systems to treat patients suffering from enlarged prostate and prostate cancer.
Ventaris Surgical, Inc.
This medical device company develops a ureteroscopic system for urologists to achieve complete stone clearance during kidney stone procedures.